International Assets Investment Management LLC Acquires New Position in Chemed Co. (NYSE:CHE)

International Assets Investment Management LLC acquired a new position in shares of Chemed Co. (NYSE:CHE) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 72,741 shares of the company’s stock, valued at approximately $437,150,000. International Assets Investment Management LLC owned about 0.48% of Chemed at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of CHE. GAMMA Investing LLC raised its position in shares of Chemed by 34.4% during the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after buying an additional 22 shares during the period. American National Bank & Trust purchased a new stake in Chemed in the third quarter valued at $61,000. EntryPoint Capital LLC lifted its stake in shares of Chemed by 14.0% in the 1st quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after purchasing an additional 18 shares during the last quarter. Mather Group LLC. lifted its stake in shares of Chemed by 60.5% in the 2nd quarter. Mather Group LLC. now owns 183 shares of the company’s stock valued at $99,000 after purchasing an additional 69 shares during the last quarter. Finally, Quarry LP grew its holdings in shares of Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock worth $103,000 after purchasing an additional 166 shares during the period. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Trading Up 0.7 %

Shares of CHE opened at $597.20 on Friday. The company’s 50-day moving average price is $585.73 and its 200 day moving average price is $570.28. Chemed Co. has a 12-month low of $502.64 and a 12-month high of $654.62. The firm has a market cap of $9.04 billion, a P/E ratio of 32.14, a price-to-earnings-growth ratio of 2.44 and a beta of 0.44.

Chemed (NYSE:CHE) last released its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). Chemed had a net margin of 12.88% and a return on equity of 29.21%. The company had revenue of $595.88 million during the quarter, compared to analysts’ expectations of $599.20 million. During the same period last year, the firm posted $4.71 earnings per share. Chemed’s revenue was up 7.6% on a year-over-year basis. Equities research analysts forecast that Chemed Co. will post 21.77 earnings per share for the current year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. This is a boost from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend was Monday, August 12th. Chemed’s dividend payout ratio is 10.76%.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the transaction, the chief executive officer now owns 103,735 shares of the company’s stock, valued at approximately $62,117,555.35. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the sale, the chief executive officer now directly owns 103,735 shares of the company’s stock, valued at $62,117,555.35. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director George J. Walsh III sold 200 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total transaction of $115,590.00. Following the completion of the transaction, the director now directly owns 3,446 shares of the company’s stock, valued at $1,991,615.70. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 9,144 shares of company stock worth $5,264,839 over the last ninety days. Company insiders own 3.32% of the company’s stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.